Global Nasal Spray Vaccine Market Size, Share, Trends and Forecast 2022-2030

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.
The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray.

Industry Insights

Due to the COVID-19 pandemic, the global Nasal Spray Vaccine market size is estimated to be worth US$ 136.8 million in 2021 and is forecast to a readjusted size of US$ 231.3 million by 2028 with a CAGR of 7.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Nasal Spray Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Nasal Spray Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal Spray Vaccine is for Adult, and the consumption proportion is about 68% in 2019.

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.

This report focuses on Nasal Spray Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Nasal Spray Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Nasal Spray Vaccine market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Child Nasal Spray Vaccine

Adult Nasal Spray Vaccine

Segment by Application

Child

Adult

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AstraZeneca FLUMIST

Cipla

BCHT

1 Nasal Spray Vaccine Market Overview
1.1 Product Overview and Scope of Nasal Spray Vaccine

1.2 Nasal Spray Vaccine Segment by Type

1.2.1 Global Nasal Spray Vaccine Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Child Nasal Spray Vaccine

1.2.3 Adult Nasal Spray Vaccine

1.3 Nasal Spray Vaccine Segment by Application

1.3.1 Global Nasal Spray Vaccine Sales Comparison by Application: (2022-2028)

1.3.2 Child

1.3.3 Adult

1.4 Global Nasal Spray Vaccine Market Size Estimates and Forecasts

1.4.1 Global Nasal Spray Vaccine Revenue 2017-2028

1.4.2 Global Nasal Spray Vaccine Sales 2017-2028

1.4.3 Nasal Spray Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028

2 Nasal Spray Vaccine Market Competition by Manufacturers

2.1 Global Nasal Spray Vaccine Sales Market Share by Manufacturers (2017-2022)

2.2 Global Nasal Spray Vaccine Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Nasal Spray Vaccine Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Nasal Spray Vaccine Manufacturing Sites, Area Served, Product Type

2.5 Nasal Spray Vaccine Market Competitive Situation and Trends

2.5.1 Nasal Spray Vaccine Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Nasal Spray Vaccine Players Market Share by Revenue

2.5.3 Global Nasal Spray Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nasal Spray Vaccine Retrospective Market Scenario by Region

3.1 Global Nasal Spray Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Nasal Spray Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Nasal Spray Vaccine Market Facts & Figures by Country

3.3.1 North America Nasal Spray Vaccine Sales by Country

3.3.2 North America Nasal Spray Vaccine Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Nasal Spray Vaccine Market Facts & Figures by Country

3.4.1 Europe Nasal Spray Vaccine Sales by Country

3.4.2 Europe Nasal Spray Vaccine Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Nasal Spray Vaccine Market Facts & Figures by Region

3.5.1 Asia Pacific Nasal Spray Vaccine Sales by Region

3.5.2 Asia Pacific Nasal Spray Vaccine Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Nasal Spray Vaccine Market Facts & Figures by Country

3.6.1 Latin America Nasal Spray Vaccine Sales by Country

3.6.2 Latin America Nasal Spray Vaccine Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Nasal Spray Vaccine Market Facts & Figures by Country

3.7.1 Middle East and Africa Nasal Spray Vaccine Sales by Country

3.7.2 Middle East and Africa Nasal Spray Vaccine Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Nasal Spray Vaccine Historic Market Analysis by Type

4.1 Global Nasal Spray Vaccine Sales Market Share by Type (2017-2022)

4.2 Global Nasal Spray Vaccine Revenue Market Share by Type (2017-2022)

4.3 Global Nasal Spray Vaccine Price by Type (2017-2022)

5 Global Nasal Spray Vaccine Historic Market Analysis by Application

5.1 Global Nasal Spray Vaccine Sales Market Share by Application (2017-2022)

5.2 Global Nasal Spray Vaccine Revenue Market Share by Application (2017-2022)

5.3 Global Nasal Spray Vaccine Price by Application (2017-2022)

6 Key Companies Profiled

6.1 AstraZeneca FLUMIST

6.1.1 AstraZeneca FLUMIST Corporation Information

6.1.2 AstraZeneca FLUMIST Description and Business Overview

6.1.3 AstraZeneca FLUMIST Nasal Spray Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.1.4 AstraZeneca FLUMIST Nasal Spray Vaccine Product Portfolio

6.1.5 AstraZeneca FLUMIST Recent Developments/Updates

6.2 Cipla

6.2.1 Cipla Corporation Information

6.2.2 Cipla Description and Business Overview

6.2.3 Cipla Nasal Spray Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Cipla Nasal Spray Vaccine Product Portfolio

6.2.5 Cipla Recent Developments/Updates

6.3 BCHT

6.3.1 BCHT Corporation Information

6.3.2 BCHT Description and Business Overview

6.3.3 BCHT Nasal Spray Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.3.4 BCHT Nasal Spray Vaccine Product Portfolio

6.3.5 BCHT Recent Developments/Updates

7 Nasal Spray Vaccine Manufacturing Cost Analysis

7.1 Nasal Spray Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Nasal Spray Vaccine

7.4 Nasal Spray Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Nasal Spray Vaccine Distributors List

8.3 Nasal Spray Vaccine Customers

9 Nasal Spray Vaccine Market Dynamics

9.1 Nasal Spray Vaccine Industry Trends

9.2 Nasal Spray Vaccine Market Drivers

9.3 Nasal Spray Vaccine Market Challenges

9.4 Nasal Spray Vaccine Market Restraints

10 Global Market Forecast

10.1 Nasal Spray Vaccine Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Nasal Spray Vaccine by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Nasal Spray Vaccine by Type (2023-2028)

10.2 Nasal Spray Vaccine Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Nasal Spray Vaccine by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Nasal Spray Vaccine by Application (2023-2028)

10.3 Nasal Spray Vaccine Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Nasal Spray Vaccine by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Nasal Spray Vaccine by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer